ADVATx
Reveal Lasers Announces Distribution Agreement With Advalight
November 10, 2022 09:00 ET | Reveal Lasers LLC
LAS VEGAS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Reveal Lasers LLC, a wholly owned subsidiary of Reveal Lasers LTD, is pleased to announce their marketing and distribution agreement with Advalight,...
logo_no_tag_2c.jpg
Sientra Announces Pricing of $13.2 Million Public Offering
October 21, 2022 07:30 ET | Sientra, Inc.
SANTA BARBARA, Calif., Oct. 21, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...
TIP_link_300x300.jpg
$7+ Billion Aesthetic Lasers Market Size to Grow at a Rapid Pace by 2028 at 16+% CAGR | The Insight Partners
October 11, 2022 10:02 ET | The Insight Partners
New York, Oct. 11, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest market study on "Aesthetic Lasers Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19...
IRB Logo.png
Aesthetics Market Size, Share, Growth [2022] | Key Vendors, Gross Margin & Revenue, Major Regions, Development Plans, Market Dynamics, Opportunities and SWOT Analysis Research Report | Industry Research Biz
September 29, 2022 05:37 ET | Industry Research
Pune, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The Global Aesthetics Market (2022-2029) research report offers an in-depth analysis of market size, share, drivers, restraints, and so on. Moreover, this...
logo_no_tag_2c.jpg
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
September 06, 2022 16:30 ET | Sientra, Inc.
SANTA BARBARA, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced...
logo_no_tag_2c.jpg
Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel
August 11, 2022 16:05 ET | Sientra, Inc.
SANTA BARBARA, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...
logo_no_tag_2c.jpg
Sientra to Report Second Quarter 2022 Financial Results on August 11, 2022
July 28, 2022 08:30 ET | Sientra, Inc.
SANTA BARBARA, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...
logo_no_tag_2c.jpg
Sientra Wins Premier’s Horizon Award for 2022 for Exceptional Customer Service, Engagement, and Value Creation
July 11, 2022 09:00 ET | Sientra, Inc.
SANTA BARBARA, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a leading medical aesthetics company focused on enhancing lives by advancing the...
logo_no_tag_2c.jpg
FDA Approves Sientra’s Low Plus Profile Projection Breast Implant
July 06, 2022 09:00 ET | Sientra, Inc.
SANTA BARBARA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) approved the Low...
Colorescience All Calm® Sensitive Skin Regimen
NEW CLINICAL STUDY DEMONSTRATES COLORESCIENCE ALL CALM® REGIMEN NEUTRALIZES REDNESS AND CALMS INFLAMED SKIN
June 29, 2022 08:30 ET | Colorescience
Carlsbad, CA, June 29, 2022 (GLOBE NEWSWIRE) -- Colorescience®, a leading dermatologist-recommended specialty skincare and cosmetics company announces published results in the Journal of Cosmetic...